Effect of α1-adrenoreceptors stimulation on electrical activity of rat atria

Cover Page

Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription Access

Abstract

The effect of methoxamine, an agonist at α1-adrenergic receptors, on the frequency of spontaneous activity and parameters of the electrical activity of the atrial myocardium was investigated in rats with normal sinus rhythm and in normal rats under continuous electrical pacing. Methoxamine exerted dual effects on the duration of repolarization of working cardiomyocytes. Methoxamine increased the duration of the repolarization phase of the action potential in normal rats under continuous electrical pacing but decreased it in rats with normal sinus rhythm.

About the authors

N. Mansour

Kazan Federal University

Email: nourm94@mail.ru
Kazan, Russia

N. I Ziyatdinova

Kazan Federal University

Kazan, Russia

A. M Gallieva

Kazan Federal University

Kazan, Russia

R. R Shakirov

Kazan Federal University

Kazan, Russia

T. L Zefirov

Kazan Federal University

Kazan, Russia

References

  1. R. M. Graham, Cleve Clin. J. Med., 57 (5), 481(1990).
  2. D. M. Perez, Front. Pharmacol., 29, 11 (2020).
  3. R. P. Ahlquist, Am. J. Physiol., 153 (3), 586 (1948).
  4. A. L. Morrow and I. Creese, Mol. Pharmacol., 29 (4), 321 (1986).
  5. D. M. Perez, M. T. Piascik, and R. M. Graham, Mol. Pharmacol., 40 (6),876 (1991).
  6. J. R. Docherty, Eur. J. Pharmacol., 855, 305 (2019).
  7. A. J. Baker, Pflugers Arch., 466 (6), 1139 (2014).
  8. T. L. Zefirov, et al., Uchenye Zapiski Kazanskogo Universiteta. Seriya Estestvennye Nauki, 160 (4), 613 (2018).
  9. S. Z. Langer, Biochem. Pharmacol., 23 (13),1793 (1974).
  10. K. B. Lai, J. E. Sanderson, and C. M. Yu, Cardiovasc. Drugs Ther., 23 (4), 271 (2009).
  11. T. D. O'Connell, B. C. Jensen, A. J. Baker, and P. C. Simpson, Pharmacol. Rev., 66 (1), 308 (2014).
  12. K. Nishimaru, M. Kobayashi, T. Matsuda, et al., AJP Heart Circ. Physiol., 280 (1), H132 (2001).
  13. M. Stengl, K. Mubagwa, E. Carmeliet, and W. Flameng, Cardiovasc. Res., 38 (3), 703 (1998).
  14. G. Gambassi, H. A. Spurgeon, E. G. Lakatta, et al., Circ. Res., 71(2), 870 (1992).
  15. A. S. Averin, L. A. Andreeva, S. S. Popova, et al., J.Comp. Physiol. B, 191, 927 (2021).
  16. S. H. Woo and C. O. Lee, Pflugers Arch., 437 (3), 335 (1999).
  17. T. L. Zefirov, I. I. Khabibrakhmanov, N. I. Ziyatdinova, and A. L. Zefirov, Bul. Exp. Biol. Med., 162 (1), 4 (2016).
  18. S. Zhang, R. Takahashi, N. Yamashita, et al., Eur. J. Pharmacol., 839, 82 (2018).
  19. J. M. Nerbonne and R. S. Kass, Physiol. Rev., 85 (4), 1205 (2005).
  20. S. A. Kodirov, V. L. Zhuravlev, T. A. Safonova, et al., Rev. Clin. Pharmacol. Drug Therapy, 3 (4), 27 (2004) [in Russian].
  21. L. Virag, N. lost, M. Opincariu, et al., Cardiovasc. Res., 49 (4), 790 (2001).
  22. E. Grandi, M. C. Sanguinetti, D. C. Bartos, et al., J. Physiol., 595 (7), 2209 (2017).
  23. I. I. Khabibrakhmanov, N. I. Ziyatdinova, and T. L. Zefirov, Russ. J. Cardiol., 26 (5), 53 (2021).

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

Copyright (c) 2023 Russian Academy of Sciences